Abstract:Cancer is one of the leading public health concerns globally; therefore it is required better drugs for treatment. Several strategies have been taken to improve the success of drug discovery. Our strategy is the exploration of organometallic platinum group metal complexes as potential anticancer drugs. Organometallic complexes bearing N-heterocyclic carbene (NHC) ligands are getting attention for therapeutic purposes. Synthesis, structure, and anticancer activities of platinum(II)- and gold(III)-N-heterocyclic carbene complexes supported by proligand 1-methyl-2-(pyridylmethyl)imidazo[1,5-a]pyridin-4-ylium hexafluorophosphate, (1.HPF6) have been described. Two novel isoelectronic and isostructural complexes, viz. [Pt(1)Cl2](2), [Au(1)Cl2][AuCl4] (3), have been synthesized and characterized by a series of spectroscopic techniques. Finally, the square planar geometry of 3 was established by single crystal X-ray diffraction studies. Interestingly, complex 3 possesses Cl--Cl interactions and this is the first organogold bears the same. Molecular docking analysis revealed the highest free binding energy for complex 3 with Human-DNA Topoisomerase. Finally, invitro anticancer studies on breast cancer cell line, MDA-MB231 revealed Au(III)-NHC complex 3 is more potent than Pt(II)-NHC complex 2. therapeutic purposes. Synthesis, structure, and anticancer activities of platinum(II)- and gold(III)-N-heterocyclic carbene complexes supported by proligand 1-methyl-2-(pyridylmethyl)imidazo[1,5-a]pyridin-4-ylium hexafluorophosphate, (1.HPF6) have been described. Two novel isoelectronic and isostructural complexes, viz. [Pt(1)Cl2](2), [Au(1)Cl2][AuCl4] (3), have been synthesized and characterized by a series of spectroscopic techniques. Finally, the square planar geometry of 3 was established by single crystal X-ray diffraction studies. Interestingly, complex 3 possesses Cl--Cl interactions and this is the first organogold bears the same. Molecular docking analysis revealed the highest free binding energy for complex 3 with Human-DNA Topoisomerase. Finally, invitro anticancer studies on breast cancer cell line, MDA-MB231 revealed Au(III)-NHC complex 3 is more potent than Pt(II)-NHC complex 2.

N-Heterocyclic Carbene (NHC) Silver Complexes as Versatile Chemotherapeutic Agents Targeting Human Topoisomerases and Actin

Catalytic and Pharmacological Activity

Synthesis of Novel NHC–Rh Complexes with Anti-Tumor Activity Against MCF-7 Human Breast Cancer Cells

Silver(I) complexes containing N-heterocyclic carbene azole drugs: Synthesis, characterization, cytotoxic activity, and their BSA interactions

Sythesis, characterisation, anticancer and antimicrobial activity of Ag-N-heterocyclic carbene complexes containing benzimidazole derivatives

Synthesis and antitumor activity of new silver(I)-N-heterocyclic carbene complexes

A symmetrical tetra N-heterocyclic carbene binuclear silver(I) complex: synthesis, characterization and anticancer study

Human colon cancer targeted pro-apoptotic, anti-metastatic and cytostatic effects of binuclear Silver(I)-N-Heterocyclic carbene (NHC) complexes

Synthesis and Anticancer Activities of some Ag(I) Complexes Involving N‐Heterocyclic Carbene Ligands

Synthesis, characterization, crystal structure and anticancer study of symmetrical binuclear bis-N-heterocyclic carbene silver(I) complexes

Design, synthesis, characterization, and biological activities of novel Ag(I)-NHC complexes based on 1,3-dioxane ligand

Novel nonsymmetrically benzimidazolium salts and their silver(I)-N-heterocyclic carbene complexes: Synthesis, DFT study and Anticancer activities

Synthesis and Biological Evaluation of Xanthone Derivatives As Anti-Cancer Agents Targeting Topoisomerase II and DNA

Synthesis and anticancer activity of silver(I)-N-heterocyclic carbene complexes derived from the natural xanthine products caffeine, theophylline and theobromine

Antitumor properties and mechanisms of mitochondria-targeted Ag(I) and Au(I) complexes containing N-heterocyclic carbenes derived from cyclophanes

New sugar-incorporated N-heterocyclic carbene precursors and their Ag(I) and Pd(II) complexes: Synthesis, characterization, and cytotoxicity studies

Synthesis and Biological Evaluation of Novel Pyrazoline Derivatives Containing Indole Skeleton As Anti-Cancer Agents Targeting Topoisomerase II.

New multifunctional hybrids as modulators of apoptosis markers and topoisomerase II in breast cancer therapy: synthesis, characterization, and in vitro and in silico studies

Structure-base design to explore the anticancer efficacy of organometallic Pt(II)- and Au(III)-N-heterocyclic carbene (NHC) complexes

Metal-N-heterocyclic carbene complexes as anti-tumor agents

Synthesis, Chemical Characterization, and Biological Evaluation of Hydrophilic Gold(I) and Silver(I) N-Heterocyclic Carbenes as Potential Anticancer Agents